期刊文献+

ALDH1L2通过过氧化物酶体通路参与调控结直肠癌细胞的辐射敏感性

ALDH1L2 Regulates the Radiosensitivity of Colorectal Cancer Cells through Peroxisome Pathway
原文传递
导出
摘要 目的:结直肠癌是我国常见且发病率逐年上升的恶性肿瘤之一。放疗是结直肠癌患者的重要治疗手段,但肿瘤的辐射抵抗是导致治疗失败及疾病复发的重要原因。本研究进一步探讨了辐射抵抗的分子机制。方法:采用生信分析筛选并研究了与结直肠癌患者无病生存率相关的基因ALDH1L2。利用过表达、敲低ALDH1L2的肠癌细胞株,通过平板克隆实验、γ-H_(2)AX蛋白量测定和彗星实验,来探究其是否与细胞的辐射敏感性相关。通过GSEA生信分析、qRT-PCR、westernblot及流式细胞学探究ALDH1L2发挥作用的可能分子机制。结果:ALDH1L2与结直肠癌患者无病生存率相关,高表达ALDH1L2提示更短的无病生存期。ALDH1L2是辐射敏感基因,其低表达可在体外加快DNA的损伤修复,促进结直肠癌细胞的辐射抵抗。ALDH1L2通过调控过氧化物酶体通路关键分子PGC1A及下游SOD2、CAT,促使胞内活性氧自由基累积导致凋亡增加,最终介导肠癌细胞的辐射敏感。结论:ALDH1L2可能通过过氧化物酶体通路来介导结直肠癌细胞的辐射敏感。 Objective:Colorectal cancer is one of the most common malignant tumors in China,and its incidence rate is increasing year by year.Radiotherapy is an important treat-ment for colorectal cancer,but the radio-resistance of tumor is an important reason resulting in treatment failure and disease recurrence.This study was carried out to study the molecular mechanism of radio-resistance in colorectal cancer.Methods:Bioinformatics analysis was used to indicate the assocication of ALDH1I2 with the disease-free survival rate of colorectal cancer patients.ALDHI L2-overexpressed or ALDHI I2 knockdown colorectal cells were used in colony formation assay,γ-H_(2)AX assay and comet assay.Gene set enrichment analysis(GSEA),qRT-PCR,westen blot and flow cytometry were used to explore possible molecular mechanisms of ALDH1I2 in mediating the radiosensitivity of colorectal cancer cells.Results:ALDH1L2 was associated with disease-free survival in pa-tients with colorectal cancer,and low expression of ALDH1I2 suggested shorter disease-free survival.Besides,ALDHII2 was a radiation-sensitive gene.Its low expression could accelerate DNA damage repair and promote radio-resistance of colorectal cancer cells in vitro.ALDH1IL2 promoted the accumulation of intracellular reactive oxygen species(ROS)by regulating the transcription and level of PGC1 A protein,the key molecule of peroxisome pathway,and its downstream mediators,SOD2 and CAT,leading to the increase of cell apoptosis,and finally mediated the radiosensitivity of colorectal cancer cells.Conclu-sion:ALDH1L2 may regulate the radiosensitivity of colorectal cancer cells through the peroxisome pathway.
作者 李双燕 翁佳雯 俞露 丁轶 Li Shuangyan;Weng Jiawen;Yu Lu;Ding Yi(Department of Radiotherapy,Nanfang Hospital,Sourthern Medical University,Guangzhou 510515,Guangdong,China;Department of Oncology,the People’s Hospital of Lincang,Lincang 677000,Yunnan,China)
出处 《肿瘤预防与治疗》 2021年第9期787-797,共11页 Journal of Cancer Control And Treatment
基金 国家自然科学基金(编号:81803063,81872470,82073342,81903125) 广东省自然科学基金(编号:2018030310297,2018A030310513) 广东省医学科学技术研究基金(编号:A2020563) 南方医科大学南方医院院长基金(编号:2020C006)。
关键词 ALDH1L2 结直肠癌 放射治疗 辐射敏感 ALDHII2 Colorectal cancer Radiotherapy Radiosensitivity
  • 相关文献

参考文献2

二级参考文献16

  • 1Kai Sun,Hai-Jun Deng,Shang-Tong Lei,Jing-Qing Dong,Guo-Xin Li.miRNA-338-3p suppresses cell growth of human colorectal carcinoma by targeting smoothened[J].World Journal of Gastroenterology,2013,19(14):2197-2207. 被引量:12
  • 2Binghong Xiong,Yong Cheng,Li Ma,Caiquan Zhang.MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signalingpathway in human colorectal cancer cells[J]. International Journal of Oncology . 2013 (1)
  • 3Mohammad Iffat Kabir Anindo,Ahmed Yaqinuddin.Insights into the potential use of microRNAs as biomarker in cancer[J]. International Journal of Surgery . 2012 (9)
  • 4Li-Ling Hsieh,Tze-Kiong Er,Chih-Chieh Chen,Jan-Sing Hsieh,Jan-Gowth Chang,Ta-Chih Liu.Characteristics and prevalence of KRAS , BRAF , and PIK3CA mutations in colorectal cancer by high-resolution melting analysis in Taiwan Residents population[J]. Clinica Chimica Acta . 2012 (19-20)
  • 5Chunzhi Zhang,Chunsheng Kang,Ping Wang,Yongzhen Cao,Zhonghong Lv,Shizhu Yu,Guangxiu Wang,Anling Zhang,Zhifan Jia,Lei Han,Chunying Yang,Hiromichi Ishiyama,Bin S. Teh,Bo Xu,Peiyu Pu.MicroRNA-221 and -222 Regulate Radiation Sensitivity by Targeting the PTEN Pathway[J]. International Journal of Radiation Oncology, Biology, Physics . 2011 (1)
  • 6Wendy De Roock,Veerle De Vriendt,Nicola Normanno,Fortunato Ciardiello,Sabine Tejpar.KRAS , BRAF , PIK3CA , and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer[J]. Lancet Oncology . 2011 (6)
  • 7Luciana Caravatta,Gilbert D. A. Padula,Vincenzo Picardi,Gabriella Macchia,Francesco Deodato,Mariangela Massaccesi,Luigi Sofo,Fabio Pacelli,Fabio Rotondi,Giuseppe Cecere,Giuseppina Sallustio,Liberato Di Lullo,Adele Piscopo,Samantha Mignogna,Pierluigi Bonomo,Numa Cellini,Vincenzo Valentini,Alessio G. Morganti.Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: Results of a phase II study[J]. Acta Oncologica . 2011 (8)
  • 8C.P. Hsu,T.Y. Kao,W.L. Chang,S. Nieh,H.L. Wang,Y.C. Chung.Clinical significance of tumor suppressor PTEN in colorectal carcinoma[J]. European Journal of Surgical Oncology . 2010 (2)
  • 9Ki‐SeokJang,Young SooSong,Si‐HyongJang,Kyueng‐WhanMin,WoongNa,Se MinJang,Young JinJun,Kang HongLee,DonghoChoi,Seung SamPaik.Clinicopathological significance of nuclear PTEN expression in colorectal adenocarcinoma[J]. Histopathology . 2009 (2)
  • 10F. T. J. Ferenschild,M. Vermaas,C. Verhoef,A. C. Ansink,W. J. Kirkels,A. M. M. Eggermont,J. H. W. Wilt.Total Pelvic Exenteration for Primary and Recurrent Malignancies[J]. World Journal of Surgery . 2009 (7)

共引文献1423

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部